Research Methods in Healthcare Epidemiology and Antimicrobial Stewardship: Use of Administrative and Surveillance Databases

Infection Control and Hospital Epidemiology

Volumn 37, Issue 11, 2016, Pages 1278-1287

  Drees, Marci ^a   Gerber, Jeffrey S ^b   Morgan, Daniel J ^c   Lee, Grace M ^d  

^a CHRISTIANA CARE HEALTH SYSTEM   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADMINISTRATIVE AND SURVEILLANCE DATA; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL STEWARDSHIP; ARTICLE; BLOODSTREAM INFECTION; CHECKLIST; DATA COLLECTION METHOD; DOCUMENTATION; ELECTRONIC HEALTH RECORD; EPIDEMIOLOGY; FOLLOW UP; HEALTH CARE; HEALTH PROGRAM; HUMAN; INFORMATION PROCESSING; INFORMED CONSENT; MEDICAL RESEARCH; METHODOLOGY; PNEUMONIA; PREDICTIVE VALIDITY; PRESCRIPTION; RECALL BIAS; RELIABILITY; SURGICAL INFECTION; CROSS INFECTION; FACTUAL DATABASE; HEALTH SERVICES RESEARCH; PROCEDURES; REPRODUCIBILITY; SENTINEL SURVEILLANCE; STANDARDS; STATISTICAL BIAS;

ANTIMICROBIAL STEWARDSHIP; BIAS; CROSS INFECTION; DATABASES, FACTUAL; EPIDEMIOLOGIC METHODS; HEALTH SERVICES RESEARCH; HUMANS; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; SENTINEL SURVEILLANCE;

EID: 84992437210     PISSN: 0899823X     EISSN: 15596834     Source Type: Journal    
DOI: 10.1017/ice.2016.189     Document Type: Article

References (100)

1. Observational Studies in a Learning Health System. Washington, DC: National Academies Press; 2013. doi:10.17226/18438
2. Meaningful use definition and objectives. US Department of Health and Human Services Office of the National Coordinator for Health Information Technology, National Learning Consortium website. https://www.healthit.gov/providers-profes sionals/meaningful-use-definition-objectives. Published 2015. Accessed December 15, 2015
3. Tan S-L, Gao G, Koch S. Big data and analytics in healthcare. Methods Inf Med 2015;54:546-547
4. Dalton BR, Sabuda DM, Bresee LC, Conly JM. Assessment of antimicrobial utilization metrics: days of therapy versus defined daily doses and pharmacy dispensing records versus nursing administration data. Infect Control Hosp Epidemiol 2015; 36(6):688-694
5. Schweizer ML, Eber MR, Laxminarayan R, et al. Validity of ICD-9-CM coding for identifying incident methicillin-resistant Staphylococcus aureus (MRSA) infections: is MRSA infection coded as a chronic disease? Infect Control Hosp Epidemiol 2011;32:148-154
6. Gehrich AP, Lustik MB, Mehr AA, Patzwald JR. Risk of postoperative urinary tract infections following midurethral sling operations in women undergoing hysterectomy. Int Urogynecol J 2015: Epub ahead of print. doi:10.1007/s00192-015-2861-z
7. Soe MM, Edwards JR, Sievert DM, Ricks PM, Magill SS, Fridkin SK. Evaluating state-specific antibiotic resistance measures derived from central line-associated bloodstream infections, National Healthcare Safety Network, 2011. Infect Control Hosp Epidemiol 2015;36:54-64
8. Lindley MC, Bridges CB, Strikas RA, et al. Influenza vaccination performance measurement among acute care hospital-based health care personnel-United States, 2013-14 influenza season. MMWR 2014;63:812-815
9. Dubberke ER, Butler AM, Yokoe DS, et al. Multicenter study of surveillance for hospital-onset Clostridium difficile infection by the use of ICD-9-CM diagnosis codes. Infect Control Hosp Epidemiol 2010;31:262-268
10. Young-Xu Y, Kuntz JL, Gerding DN, et al. Clostridium difficile infection among Veterans Health Administration patients. Infect Control Hosp Epidemiol 2015;36:1038-1045
11. Olsen MA, Nickel KB, Fox IK, et al. Incidence of surgical site infection following mastectomy with and without immediate reconstruction using private insurer claims data. Infect Control Hosp Epidemiol 2015;36:907-914
12. Perencevich EN, Sands KE, Cosgrove SE, Guadagnoli E, Meara E, Platt R. Health and economic impact of surgical site infections diagnosed after hospital discharge. Emerg Infect Dis 2003;9: 196-203
13. O'Malley KJ, Cook KF, Price MD, Wildes KR, Hurdle JF, Ashton CM. Measuring diagnoses: ICD code accuracy. Health Serv Res 2005;40(5 Pt 2):1620-1639
14. De Coster C, Quan H, Finlayson A, et al. Identifying priorities in methodological research using ICD-9-CM and ICD-10 administrative data: report from an international consortium. BMC Health Serv Res 2006;6:77
15. van Walraven C, Bennett C, Forster AJ. Administrative database research infrequently used validated diagnostic or procedural codes. J Clin Epidemiol 2011;64:1054-1059
16. Dubberke ER, Reske KA, McDonald LC, Fraser VJ. ICD-9 codes and surveillance for Clostridium difficile-associated disease. Emerg Infect Dis 2006;12:1576-1579
17. Scheurer DB, Hicks LS, Cook EF, Schnipper JL. Accuracy of ICD-9 coding for Clostridium difficile infections: a retrospective cohort. Epidemiol Infect 2007;135:1010-1013
18. Pakyz AL, Patterson JA, Motzkus-Feagans C, Hohmann SF, Edmond MB, Lapane KL. Performance of the present-onadmission indicator for Clostridium difficile infection. Infect Control Hosp Epidemiol 2015;36:838-840
19. Wen J, Barber GE, Ananthakrishnan AN. Identification of recurrent Clostridium difficile infection using administrative codes: accuracy and implications for surveillance. Infect Control Hosp Epidemiol 2015;36:893-898
20. Furuno JP, Harris AD, Wright MO, et al. Prediction rules to identify patients with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci upon hospital admission. Am J Infect Control 2004;32:436-440
21. Wright SB, Huskins WC, Dokholyan RS, Goldmann DA, Platt R. Administrative databases provide inaccurate data for surveillance of long-term central venous catheter-associated infections. Infect Control Hosp Epidemiol 2003;24:946-949
22. Tehrani DM, Russell D, Brown J, et al. Discord among performance measures for central line-associated bloodstream infection. Infect Control Hosp Epidemiol 2013;34:176-183
23. Patrick SW, Davis MM, Sedman AB, et al. Accuracy of hospital administrative data in reporting central line-associated bloodstream infections in newborns. Pediatrics 2013;131:S75-S80
24. Curtis M, Graves N, Birrell F, et al. A comparison of competing methods for the detection of surgical-site infections in patients undergoing total arthroplasty of the knee, partial and total arthroplasty of hip and femoral or similar vascular bypass. J Hosp Infect 2004;57:189-193
25. Drees M, Hausman S, Rogers A, Freeman L, Frosch K, Wroten K. Underestimating the impact of ventilator-associated pneumonia by use of surveillance data. Infect Control Hosp Epidemiol 2010;31:650-652
26. Sherman ER, Heydon KH, St John KH, et al. Administrative data fail to accurately identify cases of healthcare-associated infection. Infect Control Hosp Epidemiol 2006;27:332-337
27. Stevenson KB, Khan Y, Dickman J, et al. Administrative coding data, compared with CDC/NHSN criteria, are poor indicators of health care-associated infections. Am J Infect Control 2008; 36:155-164
28. Stamm AM, Bettacchi CJ. A comparison of 3 metrics to identify health care-associated infections. Am J Infect Control 2012; 40:688-691
29. Goto M, Ohl ME, Schweizer ML, Perencevich EN. Accuracy of administrative code data for the surveillance of healthcareassociated infections: a systematic review and meta-analysis. Clin Infect Dis 2014;58:688-696
30. Jhung MA, Banerjee SN. Administrative coding data and health care-associated infections. Clin Infect Dis 2009;49:949-955
31. Surveillance for C. difficile, MRSA, and other drug-resistant infections. Centers for Disease Control and Prevention website. http://www.cdc.gov/nhsn/acute-care-hospital/cdiff-mrsa/index. html. Published 2015. Accessed December 15, 2015
32. Durkin MJ, Baker AW, Dicks KV, et al. A comparison between National Healthcare Safety Network laboratoryidentified event reporting versus traditional surveillance for Clostridium difficile infection. Infect Control Hosp Epidemiol 2015;36:125-131
33. Baker AW, Durkin MJ, Dicks K V, et al. Methicillin-resistant Staphylococcus aureus bloodstream infection surveillance: National Healthcare Safety Network's laboratory-identified event reporting versus traditional laboratory-confirmed bloodstream infection surveillance. Infect Control Hosp Epidemiol 2014; 35:1286-1289
34. Dubberke ER, Reske KA, Yan Y, Olsen MA, McDonald LC, Fraser VJ. Clostridium difficile-associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis 2007;45:1543-1549
35. Khong CJ, Baggs J, Kleinbaum D, Cochran R, Jernigan JA. The likelihood of hospital readmission among patients with hospitalonset central line-associated bloodstream infections. Infect Control Hosp Epidemiol 2015;36:886-892
36. McGregor JC, Perencevich EN, Furuno JP, et al. Comorbidity risk-adjustment measures were developed and validated for studies of antibiotic-resistant infections. J Clin Epidemiol 2006; 59:1266-1273
37. McGregor JC, Kim PW, Perencevich EN, et al. Utility of the Chronic Disease Score and Charlson Comorbidity Index as comorbiditymeasures for use in epidemiologic studies of antibioticresistant organisms. Am J Epidemiol 2005:161483-161493
38. Daneman N, Simor AE, Redelmeier DA. Validation of a modified version of the national nosocomial infections surveillance system risk index for health services research. Infect Control Hosp Epidemiol 2009;30:563-569
39. Kanerva M, Ollgren J, Lyytikainen O, Group FPSS. Interhospital differences and case-mix a nationwide prevalence survey. J Hosp Infect 2010;76:135-138
40. Elseviers MM, Ferech M, Vander Stichele RH, Goossens H, ESAC project group. Antibiotic use in ambulatory care in Europe (ESAC data 1997-2002): trends, regional differences and seasonal fluctuations. Pharmacoepidemiol Drug Saf 2007;16:115-123
41. MacKenzie FM, Bruce J, Struelens MJ, et al. Antimicrobial drug use and infection control practices associated with the prevalence of methicillin-resistant Staphylococcus aureus in European hospitals. Clin Microbiol Infect 2007;13:269-276
42. Adriaenssens N, Coenen S, Versporten A, et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997-2009). J Antimicrob Chemother 2011;66(Suppl 6):vi3-12
43. Hicks LA, Chien Y-W, Taylor TH, Haber M, Klugman KP. Outpatient antibiotic prescribing and nonsusceptible Streptococcus pneumoniae in the United States, 1996-2003. Farley MM, Thomas S, Holst A, et al., eds. Clin Infect Dis 2011;53:631-639
44. Maselli JH, Gonzales R, Colorado Medical Society. Measuring antibiotic prescribing practices among ambulatory physicians: accuracy of administrative claims data. J Clin Epidemiol 2001;54:196-201
45. Ewen E, Willey VJ, Kolm P, McGhan WF, Drees M. Antibiotic prescribing by telephone in primary care. Pharmacoepidemiol Drug Saf 2014. doi:10.1002/pds.3686
46. Rummukainen M-L, Mäkelä M, Noro A, Finne-Soveri H, Lyytikäinen O. Assessing prevalence of antimicrobial use and infections using the minimal data set in Finnish long-term care facilities. Am J Infect Control 2013;41:e35-e37
47. Flett KB, Ozonoff A, Graham D a, Sandora TJ, Priebe GP. Impact of mandatory public reporting of central line-associated bloodstream infections on blood culture and antibiotic utilization in pediatric and neonatal intensive care units. Infect Control Hosp Epidemiol 2015;36:878-885
48. Marsteller JA, Hsu Y-J, Weeks K. Evaluating the impact of mandatory public reporting on participation and performance in a program to reduce central line-associated bloodstream infections: evidence from a national patient safety collaborative. Am J Infect Control 2014;42:S209-S215
49. Pakyz AL, Edmond MB. Influence of state laws mandating reporting of healthcare-associated infections: the case of central line-associated bloodstream infections. Infect Control Hosp Epidemiol 2013;34:780-784
50. Lee GM, Kleinman K, Soumerai SB, et al. Effect of nonpayment for preventable infections in US hospitals. N Engl J Med 2012;367:1428-1437
51. Morgan DJ, Meddings J, Saint S, et al. Does nonpayment for hospital-acquired catheter-associated urinary tract infections lead to overtesting and increased antimicrobial prescribing? Clin Infect Dis 2012;55:923-929
52. Kawai AT, Calderwood MS, Jin R, et al. Impact of the Centers for Medicare and Medicaid Services Hospital-Acquired Conditions policy on billing rates for 2 targeted healthcare-associated infections. Infect Control Hosp Epidemiol 2015;36:871-877
53. Waters TM, Daniels MJ, Bazzoli GJ, et al. Effect of Medicare's nonpayment for Hospital-Acquired Conditions: lessons for future policy. JAMA Intern Med 2015;175:347-354
54. Goudie A, Dynan L, Brady PW, Rettiganti M. Attributable cost and length of stay for central line-associated bloodstream infections. Pediatrics 2014;133:e1525-e1532
55. Hubner C, Hubner N-O, Muhr M, et al. Cost analysis of hospitalized Clostridium difficile-associated diarrhea (CDAD). GMS Hyg Infect Control 2015;10:Doc13. doi:10.3205/dgkh00 0256
56. Magee G, Strauss ME, Thomas SM, Brown H, Baumer D, Broderick KC. Impact of Clostridium difficile-associated diarrhea on acute care length of stay, hospital costs, and readmission: a multicenter retrospective study of inpatients, 2009-2011. Am J Infect Control 2015;43:1148-1153
57. Nelson RE, Jones M, Liu C-F, et al. The impact of healthcareassociated methicillin-resistant Staphylococcus aureus infections on post-discharge healthcare costs and utilization. Infect Control Hosp Epidemiol 2015;36:534-542
58. Thakore R V, Greenberg SE, Shi H, et al. Surgical site infection in orthopedic trauma: A case-control study evaluating risk factors and cost. J Clin Orthop Trauma 2015;6:220-226
59. Wilson MZ, Rafferty C, Deeter D, Comito MA, Hollenbeak CS. Attributable costs of central line-associated bloodstream infections in a pediatric hematology/oncology population. Am J Infect Control 2014;42:1157-1160
60. Mauldin PD, Salgado CD, Hansen IS, Durup DT, Bosso JA. Attributable hospital cost and length of stay associated with health care-associated infections caused by antibiotic-resistant Gram-negative bacteria. Antimicrob Agents Chemother 2010; 54:109-115
61. Bejko J, Tarzia V, Carrozzini M, et al. Comparison of efficacy and cost of iodine impregnated drape vs. standard drape in cardiac surgery: study in 5100 patients. J Cardiovasc Transl Res 2015;8:431-437
62. Bessesen MT, Lopez K, Guerin K, et al. Comparison of control strategies for methicillin-resistant Staphylococcus aureus. Am J Infect Control 2013;41:1048-1052
63. Ghosh A, Jiao L, Al-Mutawa F, O'Neill C, Mertz D. Value of an active surveillance policy to document clearance of meticillinresistant Staphylococcus aureus and vancomycin-resistant enterococci amongst inpatients with prolonged admissions. J Hosp Infect 2014;88:230-233
64. Goldsack JC, DeRitter C, Power M, et al. Clinical, patient experience and cost impacts of performing active surveillance on known methicillin-resistant Staphylococcus aureus positive patients admitted to medical-surgical units. Am J Infect Control 2014;42:1039-1043
65. Brilli RJ, McClead REJ, Crandall W V, et al. A comprehensive patient safety program can significantly reduce preventable harm, associated costs, and hospital mortality. J Pediatr 2013;163:1638-1645
66. Slayton RB, Scott RD, Baggs J, Lessa FC, McDonald LC, Jernigan JA. The cost-benefit of federal investment in preventing Clostridium difficile infections through the use of a multifaceted infection control and antimicrobial stewardship program. Infect Control Hosp Epidemiol 2015;36:681-687
67. Finkler SA. The distinction between cost and charges. Ann Intern Med 1982;96:102-109
68. Federal Policy for the Protection of Human Subjects, Docket ID number HHS-OPHS-2015-0008. United States Government website. http://federalregister.gov/a/2015-21756. Published 2015. Accessed December 23, 2015
69. Stringham J, Young N. Using MedPAR data as a measure of urinary tract infection rates: implications for the Medicare inpatient DRG payment system. Perspect Heal Inf Manag 2005;2:12
70. McHugh M, Martin TC, Orwat J, Dyke K Van. Medicare's policy to limit payment for hospital-acquired conditions: the impact on safety net providers. J Health Care Poor Underserved 2011;22:638-647
71. Calderwood MS, Kleinman K, Soumerai SB, et al. Impact of Medicare's payment policy on mediastinitis following coronary artery bypass graft surgery in US hospitals. Infect Control Hosp Epidemiol 2014;35:144-151
72. Calderwood MS, Kleinman K, Bratzler DW, et al. Medicare claims can be used to identify US hospitals with higher rates of surgical site infection following vascular surgery. Med Care 2014;52:918-925
73. Owens PL, Barrett ML, Raetzman S, Maggard-Gibbons M, Steiner CA. Surgical site infections following ambulatory surgery procedures. JAMA 2014;311:709-716
74. Aparasu RR, Chatterjee S, Chen H. Risk of pneumonia in elderly nursing home residents using typical versus atypical antipsychotics. Ann Pharmacother 2013;47:464-474
75. Krishnarajah G, Landsman-Blumberg P, Eynullayeva E. Rotavirus vaccination compliance and completion in a Medicaid infant population. Vaccine 2015;33:479-486
76. Landrum ML, Neumann C, Cook C, et al. Epidemiology of Staphylococcus aureus blood and skin and soft tissue infections in the US military health system, 2005-2010. JAMA 2012;308: 50-59
77. Romley JA, Chen AY, Goldman DP, Williams R. Hospital costs and inpatient mortality among children undergoing surgery for congenital heart disease. Health Serv Res 2014;49:588-608
78. Poeran J, Mazumdar M, Rasul R, et al. Antibiotic prophylaxis and risk of Clostridium difficile infection after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg 2015; epub ahead. doi:10.1016/j.jtcvs.2015.09.090
79. Parker SL, McGirt MJ, Murphy JA, Megerian JT, Stout M, Engelhart L. Comparative effectiveness of antibiotic-impregnated shunt catheters in the treatment of adult and pediatric hydrocephalus: analysis of 12,589 consecutive cases from 287 US hospital systems. J Neurosurg 2015;122:443-448
80. Baker M, Yokoe DS, Stelling J, et al. Automated outbreak detection of hospital-associated infections. ID Week, San Diego, CA. Infectious Diseases Society of America website. https://idsa. confex.com/idsa/2015/webprogram/Paper52912.html. Published 2015. Accessed December 23, 2015
81. Gulliford MC, Dregan A, Moore M V, et al. Continued high rates of antibiotic prescribing to adults with respiratory tract infection: survey of 568 UK general practices. BMJ Open 2014;4(10): e006245. doi:10.1136/bmjopen-2014-006245
82. Currie CJ, Berni E, Jenkins-Jones S, et al. Antibiotic treatment failure in four common infections in UK primary care 1991-2012: longitudinal analysis. BMJ 2014;349:g5493
83. Hicks LA, Taylor TH, Hunkler RJ. U.S. outpatient antibiotic prescribing, 2010. N Engl J Med 2013;368:1461-1462
84. Fleurence RL, Curtis LH, Califf RM, Platt R, Selby J V, Brown JS. Launching PCORnet, a national patient-centered clinical research network. J Am Med Inform Assoc. 21:578-582
85. McNeil MM, Gee J, Weintraub ES, et al. The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety. Vaccine 2014;32:5390-5398
86. Messina JA, Cober E, Richter SS, et al. Hospital readmissions in patients with carbapenem-resistant Klebsiella pneumoniae. Infect Control Hosp Epidemiol 2015:1-8
87. Gerber JS, Prasad PA, Russell Localio A, et al. Variation in antibiotic prescribing across a pediatric primary care network. J Pediatric Infect Dis Soc 2015;4:297-304
88. Tartof SY, Rieg GK, Wei R, Tseng HF, Jacobsen SJ, Yu KC. A comprehensive assessment across the healthcare continuum: risk of hospital-associated Clostridium difficile infection due to outpatient and inpatient antibiotic exposure. Infect Control Hosp Epidemiol 2015;36:1409-1416
89. Padia R, Olsen G, Henrichsen J, et al. Hospital and surgeon adherence to pediatric tonsillectomy guidelines regarding perioperative dexamethasone and antibiotic administration. Otolaryngol Neck Surg 2015;153:275-280
90. Ju MH, Ko CY, Hall BL, Bosk CL, Bilimoria KY, Wick EC. A comparison of 2 surgical site infection monitoring systems. JAMA Surg 2015;150:51-57
91. Furuya EY, Dick A, Perencevich EN, Pogorzelska M, Goldmann D, Stone PW. Central line bundle implementation in US intensive care units and impact on bloodstream infections. PLoS One 2011;6(1):e15452. doi:10.1371/journal.pone.0015452
92. Nayar V, Kennedy A, Pappas J, et al. Improving cardiac surgical site infection reporting and prevention by using registry data for case ascertainment. Ann Thorac Surg 2016; 101:190-199
93. Salmon D, Yih WK, Lee G, et al. Success of program linking data sources to monitor H1N1 vaccine safety points to potential for even broader safety surveillance. Health Aff (Millwood) 2012;31:2518-2527
94. Yih WK, Lee GM, Lieu TA, et al. Surveillance for adverse events following receipt of pandemic 2009 H1N1 vaccine in the Post-Licensure Rapid Immunization Safety Monitoring (PRISM) System, 2009-2010. Am J Epidemiol 2012;175:1120-1128
95. McGregor JC, Bearden DT, Townes JM, et al. Comparison of antibiograms developed for inpatients and primary care outpatients. Diagn Microbiol Infect Dis 2013;76:73-79
96. Logan LK, Braykov NP, Weinstein RA, Laxminarayan R, CDC Epicenters Prevention Program. Extended-spectrum β-lactamase-producing and third-generation cephalosporin-resistant Enterobacteriaceae in children: trends in the United States, 1999-2011. J Pediatric Infect Dis Soc 2014;3:320-328
97. McDonald LT, Clark AM, Landauer AK, Kuxhaus L. Winning the war on surgical site infection: evidence-based preoperative interventions for total joint arthroplasty. AORN J 2015;102:182. e1-182.e11
98. Toltzis P, O'Riordan M, Cunningham DJ, et al. A statewide collaborative to reduce pediatric surgical site infections. Pediatrics 2014;134:e1174-e1180
99. Saving lives and saving money: hospital-acquired conditions update; interim data from national efforts to make care safer, 2010-2014. Agency for Healthcare Research and Quality website http://www.ahrq.gov/professionals/quality-patient-safety/ pfp/interimhacrate2014.html. Published 2014. Accessed December 29, 2015
100. Morris MS, Deierhoi RJ, Richman JS, Altom LK, Hawn MT. The relationship between timing of surgical complications and hospital readmission. JAMA Surg 2014;149:348-354